在瘤发育过程中,TBK1具有悖论性作用:专注于介导IFN-I表达的途径
Banglu Wang1, Fan Zhang1, Xiaoyu Wu1
1Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Frontiers in immunology
|August 20, 2024
概括
坦克结合激酶1 (TBK1) 在癌症中具有双重作用,通过免疫反应促进和抑制瘤生长. 了解TBK1-干扰素信号传递对于开发有效的癌症疗法至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 坦克结合激酶1 (TBK1) 对于非正规NF-κB和I型干扰素 (IFN-I) 反应至关重要.
- 异常的TBK1激活在特定情况下促进瘤细胞的增殖和存活.
- 目前的TBK1抑制剂尽管正在进行研究,但其临床疗效有限.
研究的目的:
- 在各种瘤环境中审查TBK1信号通路.
- 总结TBK1在瘤促进和抑制方面的双重作用.
- 突出TBK1-IFN途径在癌症治疗和免疫反应中的重要性.
主要方法:
- 在癌症中对TBK1信号的文献综述.
- 分析TBK1在先天性免疫激活和IFN-I产生中的作用.
- 检查TBK1对瘤进展的悖论性影响.
主要成果:
- TBK1 作为先天免疫的一个关键节点,通过 IFN-I 调解抗瘤反应.
- 根据背景,TBK1表现出促进瘤和抑制瘤的作用.
- 下游的IFN-I信号级联影响TBK1在瘤发展中的悖论性作用.
结论:
- 结核基因1在癌症中的双重作用需要考虑其下游的IFN-I信号传导.
- 准TBK1-IFN通路对新型癌症免疫疗法具有前景.
- 预计TBK1抑制剂的进一步进展将改善癌症治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


